Malignant T cells from advanced CTCL show a Th2-dominant phenotype, characterized by the secretion of IL-4, IL-5, IL-10, and IL-13 with low IFNγ production [14,44]. The gene discussed is IL13; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.